CMPX

Compass Therapeutics, Inc. SEC filings

Every EDGAR filing for Compass Therapeutics, Inc. (CMPX), newest first, with AI summaries and stories.

Ticker: CMPX
CIK: 1738021
Sector: Biotech and pharma
Latest filing: Oct 2

Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

ROUTINE4Compass Therapeutics, Inc.CMPXOct 2
Compass Therapeutics, Inc. (CMPX) reports stock transaction.
- Neil Lerner, Chief Accounting Officer, acquired 20,000 shares on 10/01/2026.
- Lerner now holds 420,000 shares directly.
- 62,500 unvested RSUs granted on 1/2/2026, vesting over 4 years.
Company Filing
Neil Lerner
ROUTINE4Compass Therapeutics, Inc.CMPXSep 25
Neil Lerner, insider filing for CMPX
Company Filing
Neil Lerner, reporting
ROUTINE8-KCompass Therapeutics, Inc.CMPXSep 22
Current report
Company Filing
ROUTINESCHEDULE 13G/ACompass Therapeutics, Inc.CMPXAug 14
Ownership stake disclosure by Vivo Opportunity Fund Holdings, L.P. (amended)
Company Filing
Vivo Opportunity Fund Holdings, L.P., filed by
ROUTINESCHEDULE 13GCompass Therapeutics, Inc.CMPXAug 7
Ownership stake disclosure by STATE STREET CORP
Company Filing
STATE STREET CORP, filed by
NOTABLE10-QCompass Therapeutics, Inc.CMPXAug 6
Quarterly report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXAug 6
Current report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXJul 1
Current report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXJun 11
Current report
Company Filing
ROUTINESCHEDULE 13G/ACompass Therapeutics, Inc.CMPXMay 15
Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
Company Filing
BIOTECHNOLOGY VALUE FUND L P, filed by
NOTABLE10-QCompass Therapeutics, Inc.CMPXMay 5
Quarterly report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXMay 5
Current report
Company Filing
ROUTINE4/ACompass Therapeutics, Inc.CMPXApr 30
2 insider filings
Neil Lerner, insider filing for CMPX (amended)
Show all 2
- 4/AInsider filing for CMPX (amended)Apr 30
- 4/AInsider filing for CMPX (amended)Apr 30
Neil Lerner, reporting
ROUTINE4Compass Therapeutics, Inc.CMPXApr 29
2 insider filings
Jonathan Anderman, insider filing for CMPX
Show all 2
- 4Insider filing for CMPXApr 29
- 4Insider filing for CMPXApr 29
Jonathan Anderman, reporting
ROUTINEARSCompass Therapeutics, Inc.CMPXApr 29
Annual report to shareholders
Company Filing
ROUTINEDEFA14ACompass Therapeutics, Inc.CMPXApr 29
Additional proxy materials
Company Filing
ROUTINEDEF 14ACompass Therapeutics, Inc.CMPXApr 29
Proxy statement
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXApr 27
Current report
Company Filing
ROUTINES-8Compass Therapeutics, Inc.CMPXMar 12
Employee stock plan registration
Company Filing
NOTABLE10-KCompass Therapeutics, Inc.CMPXMar 5
Annual report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXMar 5
Current report
Company Filing
ROUTINESCHEDULE 13G/ACompass Therapeutics, Inc.CMPXFeb 13
Ownership stake disclosure by Blackstone Holdings II L.P. (amended)
Company Filing
Blackstone Holdings II L.P., filed by
ROUTINE4Compass Therapeutics, Inc.CMPXFeb 10
Thomas J. Schuetz, insider filing for CMPX
Company Filing
Thomas J. Schuetz, reporting
ROUTINE4Compass Therapeutics, Inc.CMPXJan 12
Thomas J. Schuetz, insider filing for CMPX
Company Filing
Thomas J. Schuetz, reporting
ROUTINEEFFECTCompass Therapeutics, Inc.CMPXJan 8
Registration declared effective
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXJan 6
Current report
Company Filing
ROUTINE4Compass Therapeutics, Inc.CMPXJan 5
14 insider filings
Thomas J. Schuetz, insider filing for CMPX
Show all 14
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 3New insider at CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 4Insider filing for CMPXJan 5
- 3New insider at CMPXJan 5
Thomas J. Schuetz, reporting
ROUTINEDEL AMCompass Therapeutics, Inc.CMPXDec 31, 2025
DEL AM filing
Company Filing
ROUTINES-3Compass Therapeutics, Inc.CMPXDec 30, 2025
Securities offering
Company Filing
ROUTINESCHEDULE 13GCompass Therapeutics, Inc.CMPXNov 14, 2025
Vivo Opportunity Fund Holdings, L.P. filed a Schedule 13G disclosing a 5.1% ownership stake in Compass Therapeutics, Inc. (CMPX), a biopharmaceutical company.
Company Filing
Vivo Opportunity Fund Holdings, L.P., filed by
ROUTINESCHEDULE 13G/ACompass Therapeutics, Inc.CMPXNov 14, 2025
2 13G filings
Ownership stake disclosure by TANG CAPITAL MANAGEMENT LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)Nov 14, 2025
- SCHEDULE 13G/AOwnership stake disclosure (amended)Nov 14, 2025
TANG CAPITAL MANAGEMENT LLC, filed by
NOTABLE10-QCompass Therapeutics, Inc.CMPXNov 5, 2025
Quarterly report
Company Filing
ROUTINE8-KCompass Therapeutics, Inc.CMPXNov 5, 2025
Current report
Company Filing

Older filings on EDGAR

Get an email when Compass Therapeutics, Inc. files

Filings

Compass Therapeutics, Inc. (CMPX) reports stock transaction.

2 insider filings

2 insider filings

14 insider filings

Vivo Opportunity Fund Holdings, L.P. filed a Schedule 13G disclosing a 5.1% ownership stake in Compass Therapeutics, Inc. (CMPX), a biopharmaceutical company.

2 13G filings